Related Experiment Videos
Therapeutic options for severe pulmonary hypertension
1Pulmonary and Critical Care Division, Hospital of the University of Pennsylvania Medical Center, Philadelphia, USA.
Clinics in Chest Medicine
|November 5, 1997
Summary
Pulmonary hypertension, a condition of elevated pulmonary vascular resistance, has seen advances in understanding and treatment. This review covers nonspecific, pharmacologic, and surgical therapies for managing this progressive disease.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Background:
- Pulmonary hypertension (PH) arises from diverse conditions causing elevated pulmonary vascular resistance.
- Significant advancements in understanding PH pathogenesis and treatment have occurred over the last decade.
- Therapeutic strategies encompass pharmacologic and, in select cases, surgical interventions.
Purpose of the Study:
- To review current therapeutic options for pulmonary hypertension.
- To discuss nonspecific management strategies applicable to all PH patients.
- To detail vasodilator therapies and surgical considerations for specific PH cases.
Main Methods:
- Literature review of recent advancements in pulmonary hypertension treatment.
- Discussion of pharmacologic approaches including oral, intravenous, and inhalational agents.
- Analysis of surgical options for specific pulmonary hypertension circumstances.
Main Results:
- Nonspecific therapies are foundational for all pulmonary hypertension patients.
- Vasodilator therapy, including screening for responsiveness and various drug formulations, is a cornerstone of treatment.
- Surgical interventions offer viable options for select patient populations.
Conclusions:
- Comprehensive management of pulmonary hypertension involves a multi-faceted approach.
- Pharmacologic therapies, particularly vasodilators, are central to treatment strategies.
- Surgical options should be considered for appropriate candidates with pulmonary hypertension.